SHANGHAI, Feb. 13,
2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD)
("Zhongchao" or the "Company"), a platform-based internet
technology company offering services to patients with oncology and
other major diseases, today announced that its MDMOOC Platform will
apply the ChatGPT (Chat Generative Pre-trained Transformer) to
provide assistance for physicians in clinical decision-making to
improve the efficiency of diagnosis and treatment. This is an
expanded application of ChatGPT by Zhongchao since its initial
application of ChatGPT to elevate patient management service
capabilities and experience.
The application of ChatGPT will be available on the MDMOOC
ChatGPT Wechat Public Account ("MDMOOC ChatGPT"), a public account
on WeChat. Physicians can utilize MDMOOC ChatGPT to access the
latest information on diseases, diagnostic criteria, treatment
options, research data, and guidelines. In addition, physicians
will be alerted that contents provided by ChatGPT will be solely
for reference and convenience to users and shall not be relied on
for diagnostic or treatment purposes. The application of ChatGPT
will allow physicians to quickly comprehend multidisciplinary
knowledge and clinical data as needed in developing comprehensive
and up-to-date treatment plans for individual patients.
Given sheer volume and complexity of medical information, and
numerous disease types, the potential for multiple health issues in
a single patient, and the need for a more nuanced approach to
patient treatment solution among multiple treatment options,
physicians must consider a wide range of factors, including the
latest evidence-based recommendations, the patient's unique medical
history, and their own clinical experience which requires a deep
understanding of medical knowledge and advanced clinical thinking
skills. Zhongchao believes that applying ChatGPT to support
clinical diagnosis and treatment decisions will improve the
efficiency of these processes. In particular, this approach will
bridge the knowledge gap and reduce the disparity among physicians
regardless of locations, facilities and supports they possess. In
addition, MDMOOC ChatGPT can contribute in research, such as
generating research outlines and pinpointing relevant research
topics. Zhongchao plans to continue leveraging the advanced
thinking and computing capabilities of ChatGPT in its other
platforms and businesses to offer innovative and convenient
services and experiences to both physicians and patients alike.
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It conducts
operations in China through the
contractual arrangements between its wholly owned subsidiary and
PRC operating entities. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 21-3220-5987
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-announces-the-application-of-chatgpt-for-its-mdmooc-platform-to-assist-physicians-in-clinic-decision-making-and-improve-treatment-efficiency-301744641.html
SOURCE Zhongchao Inc.